RankAlpha logo
Back to Rankings

GPCR

Structure TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
GPCR vs peer average
41/100
GPCR vs. peer average (D vs. C)
Grade spread
A 1 · B 1 · C 4 · D 2 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

MRNA is the first available peer comparator.

Large-cap RNA/modality peer with established commercialization; useful comparator for platform valuation dynamics.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerMRNAModerna
GPCR
Structure Therapeutics
MRNA
Moderna
Grade
D
F
Momentum
14
100
Value
41
41
Sentiment
42
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs MRNA

GPCR / MRNA
Grade Position
Below peers
GPCR vs. peer average (D vs. C)
41/100
Momentum
14
MRNA
Value
41
GPCR
Sentiment
42
GPCR

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs GPCR
1
MRNA
MRNA
F
20/100
+1
2
IONQ
IONQ
C
60/100
-1
3
ALNY
ALNY
C
60/100
-1
4
DNLI
Denali Therapeutics Inc Common
C
60/100
-1
5
RCUS
Arcus Biosciences Inc Common
C
60/100
-1
MRNA is the first peer returned for this comparison set.